Metastasis is the primary cause of mortality associated with cancer. Molecular mechanisms leading to metastatic spread are poorly studied. To get a better understanding of this process, we compared the gene expression pattern of two isogenic cell lines, HET-SR and HET-SR1 (Rous Sarcoma Virus-transformed embryo hamster fibroblasts) with different metastatic activity using the differential display technique. A novel cDNA of hamster gene shMDG1 (Syrian hamster homologue of microvascular differentiation gene 1), which had 94% homology with rat MDG1 gene, was identified. Expression of shMDG1 was increased in low metastatic HET-SR cell line in comparison to high metastatic HET-SR1. Sequence analysis of the ORF of shMDG1 gene showed that it belongs to the DnaJ/heat-shock proteins of 40 kDa (HSP40) chaperones family, considered to function as a cochaperone of HSP70 family. In order to confirm involvement of shMDG1 in metastasis, we injected parental and shMDG1 overexpressed cells into animals. We showed that overexpression of the shMDG1 gene significantly diminished the metastatic activity of both HET-SR and HET-SR1 cells. The shMDG1-induced repression of metastasis was not connected with alterations in cell proliferation and motility in vitro, but correlated well with a decrease in content of the Asnlinked b1-6 branched oligosaccharides on cell surface. Oncogene ( The process of metastasis is a complex series of stochastic events (Hanahan and Weinberg, 2000; Chambers et al., 2002) . Former metastatic cells detach from primary tumor mass, invade small vessels, survive the mechanical stresses of circulation, and finally extravagate and proliferate at a distant site. During this entire process, tumor cell evade or resist host defense mechanisms, such as cytotoxic T-lymphocytes, macrophages, NK cells, and neutrophils. Only a very small percentage of cancer cells are capable of forming distant metastasis (Nicolson, 1991) . Nevertheless, metastasis is the most fearsome aspect of cancer. The majority of patients with cancer die because of metastatic spread of primary tumor.
The process of metastasis is a complex series of stochastic events (Hanahan and Weinberg, 2000; Chambers et al., 2002) . Former metastatic cells detach from primary tumor mass, invade small vessels, survive the mechanical stresses of circulation, and finally extravagate and proliferate at a distant site. During this entire process, tumor cell evade or resist host defense mechanisms, such as cytotoxic T-lymphocytes, macrophages, NK cells, and neutrophils. Only a very small percentage of cancer cells are capable of forming distant metastasis (Nicolson, 1991) . Nevertheless, metastasis is the most fearsome aspect of cancer. The majority of patients with cancer die because of metastatic spread of primary tumor.
It is believed that metastasis formation involves an intricate interplay between altered expression of genes regulating cell adhesion, migration, lymph-/angiogenesis, and survival and proliferation in unusual microenvironment. Numerous gene products involved in the metastasis formation were identified, but this is still not enough for the complete understanding of the process (Chambers et al., 2002) .
To learn more about basic mechanisms that underlie metastasis, we compared two isogenic cell lines: HET-SR and HET-SR1 showing different metastatic activity (Deichman et al., 1989) . These cell lines were obtained by independent infections in vitro of primary hamster fibroblasts with two derivatives of Rous Sarcoma Virus Schmidt-Ruppin strain (RSV SR-D) containing several mutations in v-src gene (Tatosyan et al., 1996) . Previously we showed that substitution of the three amino acids (E 522 -D, V 541 -M, A 543 -E) and one deletion (V 524 ) in the C-terminal regulation domain of v-src determinate the difference in the ability of HET-SR and HET-SR1 cell lines to form metastasis (Tatosyan et al., 1996) . Isoform of v-src from high metastatic line HET-SR1 was named as v-srcHM and from low metastatic line HET-SR was named as v-srcLM. We proposed that alteration of v-src structure reflects the difference in cell signaling and thereafter in metastasis formation. To define genes affecting metastatic activity, we compared the gene expression patterns of HET-SR and HET-SR1 cell lines using the RT-PCR-based differential display strategy (Liang and Pardee, 1992) .
We identified several differentially expressed transcripts (Chepurnykh et al., 2000) . One of them (365 bp length) was expressed in higher level in low metastatic cell line HET-SR compared with high metastatic cell line HET-SR1 (Figure 1a ). Sequence analysis of the 365 bp fragment revealed significant homology with the rat Mdg1 (microvascular differentiation gene 1), mouse (mDj7), and human (DNJB9) genes ( Figure 1c ) (Prols et al., 2001; Shen et al., 2002) . We generated the fulllength (981 bp) shMDG1 (Syrian hamster homolog of microvascular differentiation gene 1) that contains an open-reading frame of 669 bp (Figure 1c ). The sequence of shMDG1 is available in GenBank under Accession Number AY532644. Northern blot analysis revealed a significant decrease of shMDG1 gene expression in high metastatic cell line HET-SR1 compared with low metastatic cell line HET-SR and thus confirmed the differential display data (Figure 1b) . shMDG1 belongs to the family of heat-shock proteins of 40 kDa -HSP40/DnaJ (Figure 1d ). The HSPs (chaperones) comprise a lot of proteins with different molecular weights (100, 90, 70, 60, 40 , and 27 kDa) highly produced after exposure to a variety of cellular stresses such as heat, heavy metals, anoxia, and glucose starvation (Welch, 1990; Morimoto, 1991; Ohtsuka and Hata, 2000) . HSP40/DnaJ proteins act as cochaperones and specific factors for HSP70 proteins (Yochem et al., 1978) . The special feature of DnaJ protein family is a J domain, a highly conserved tetrahelical domain that binds to HSP70 chaperones and activates their ATPase Figure 1 (a) Analysis of gene expression in HET-SR and HET-SR1 cell lines by differential display. Differential display was performed using the RNAmap kit (GeneHunter). Briefly, 2 mg of total RNA were used as a template for reverse transcriptase reaction using 5 mM dT12MG (M can either be dA, dC, or dG), 20 mM dNTPs and 200 U MMLV reverse transcriptase. dT12MG (as a 3 0 -primer) and AP-1 (5 0 -AGCCAGCGAA-3 0 ; as a 5 0 -primer) were used for the subsequent PCR reaction. PCR products were separated on a 6% polyacrylamide gel and bands were visualized by autoradiography. Fragments of interest were reamplified and sequenced. (b) Analysis of the shMDG1 gene expression in HET-SR and HET-SR1 cell lines. Total mRNA was isolated from cells using Trizol Reagent (Gibco BRL) according to the manufacturer's instructions. In all, 30 mg of each fraction per lane was loaded. Northern blot was performed using [a-32 P]labeled shMDG1 fragment. Hybridized membrane was exposed for 30 days for shMDG1 probe and 2 days for GAPDH probe. Hybridization with GAPDH was used as load control. Densitometric analysis revealed that the shMDG1 expression level was about three-fold upregulated in low metastatic line HET-SR comparing with high metastatic line HET-SR1. (c) Sequence analysis of shMDG1 cDNA. Comparison of shMDG1 nucleotide sequence of human (h) ERdj4, mouse (m) mDj7, and rat (r) Mdg1 genes. Gray boxes indicate 365 bp nucleotide sequence, which was obtained by differential display. shMDG1 full-length cloning. In order to obtain the complete 5 0 -end of shMDG1, we performed RT-PCR using total RNA from HET-SR cells according to the protocol supplied by the manufacturer (Clontech). The template-specific primer used for the reverse transcriptase reaction was mdg1-start (5 0 -GAAATGGCTACTCCACAGTC-3 0 ) and mdg1-anti (5 0 -GGGTATGGCCAAATTAGTGAG-3 0 ). Mdg1-start was chosen on the basis of alignment of the three genes: rat Mdg1, mouse mDj7, and human DNJB9 genes. The PCR fragment was subcloned into TA-cloning vector pCR2.1 (Invitrogen) and sequenced using T7 or M13 reverse primer to obtain the full-length shMdg1 cDNA. For the next experiments, we constructed pLV-shMdg1 by subcloning the open-reading frame of shMdg1-cDNA from pCR2.1 into pLV plasmid via EcoRI/ApaI sites. pLV and pLV-EGFP (which was used as a control) plasmids were the generous gift of Dr Peter Chumakov (Lerner Research Institute, CCF, USA). (d) Comparison of shMDG1 amino-acid sequence with human (h) DNJB9, mouse (m) mDj7, and rat (r) Mdg1. Gray and white boxes indicate complete or partial homology, respectively. Boxed letters (7-23 amino acids) indicate the predicted signal peptide and the J domain (24-93 amino acids). The amino-acid and the nucleotide sequences were aligned using NClustalW (ver. 1.16.2.6., http://srs.ebi.ac.uk).
shMDG1 affects metastatic potential of transformed cells N Isachenko et al activity. HSP40/HSP70 system is involved in protein folding, protein degradation, assembling, and disassembling of multiprotein complexes and translocation of proteins across membranes. It has been shown that rat homolog of shMDG1 protein was localized in the endoplasmic reticulum (ER) membrane and was upregulated only under ER stress conditions, but not by heat or other shocks (Prols et al., 2001; Shen et al., 2002) . Human homolog was identified as a component of the ER-associated degradation system (Shen et al., 2002) . It may lead to the suggestion that shMDG1 plays an important role in either the protein refolding or/and the retrotranslocation of misfolded proteins including glycosylation enzymes.
It has been shown that human homolog of shMDG1 is localized on chromosome segment 14q24.2-q24.3 (Prols et al., 1997) . The loss of this sequences correlate with colorectal metastasis formation and glioma progression (Thorstensen et al., 2001; Dichamp et al., 2004) .
To define whether shMDG1 expression could affect metastatic activity of tumor cells, we overexpressed shMDG1 in HET-SR and HET-SR1 cell lines by transduction of lentivirus containing the shMDG1 gene. Overexpression of shMDG1 in transduced cell lines was confirmed by Northern blot analysis (Figure 2a) . First, we studied the effect of shMDG1 overexpression on tumorigenicity of HET-SR and HET-SR1 cells, that is, their ability to form tumors after injection into novel microenvironment. This test can reflect some aspects of metastasis. We measured the tumorigenicity index (TrD 50 ) as a decimal logarithm of a number of cells causing tumors in 50% of hamsters after injection of different cell numbers (2 Â 10 4 ; 2 Â 10 3 ; 2 Â 10 2 ; 2 Â 10 1 ) into four legs of each animal (Deichman et al., 1989) . It was found that expression of the shMDG1 increased the TrD 50 index for both HET-SR and HET-SR1 cells about three-fold (Mann-Whitney U-test, Po0.0001). At higher cell dosages (2 Â 10 4 cells/per leg), we found no Figure 2 (a) Verification of shMDG1 mRNA expression level in HET-SR/shMDG1 and HET-SR1/shMDG1 cell lines. HET-SR and HET-SR1 cells were infected by lentivirus bearing the shMDG1 gene. Lentiviral vectors were generated as described previously (Blomer et al., 1997) . Briefly, A293 cells were transfected transiently by packaging plasmid, an envelope plasmid (vesicular stomatitis virus G protein (VSV-G)), and the expression vector pLV-shMDG1 (pLV-GFP was used as a control). In all, 4 mg of DNA per 100 mm Petri dish was used for Lipofectamine transfection technique as recommended by the manufacturer (Invitrogen). We harvested the condition media-containing virus after 48 and 72 h, filtered the medium through 0.45 mm filters, and used the virus containing media either fresh or as frozen aliquots. A total of 4 Â 10 4 HET-SR and HET-SR1 cells per well were transduced in a six-well plate with 1 ml of the viral supernatant in the presence of 4 mg of Polybrene/ml. After 24 h, the medium was replaced by a fresh one. Transfectants were selected using 600 mg/ ml of G418. Northern blot analysis was carried out as described above. Hybridized membrane was exposed for 2 days (for shMDG1 and for GAPDH probes). (b) Distributions of lung metastases in spontaneous metastatic activity (SMA) test. All cell cultures used for injection were in log-phase growth. Tumor cells were injected subcutaneously (2 Â 10 4 cells, 10 animals per group). After 60 days, the animals were killed and pulmonary metastases scored. To prove the influence of shMDG1 expression on metastatic potential, we used two specific tests: SMA (spontaneous metastatic activity) and EMA (experimental metastasis activity). SMA was estimated by counting of tumor foci in the lung 8 weeks after subcutaneous injection of 2 Â 10 4 cells (at this cell dosage all tested cell lines formed subcutaneous tumors of approximately equal size in 100% of animals). In agreement with previous report (Tatosyan et al., 1996) , original HET-SR and HET-SR1 cell lines showed mainly different levels of their SMA: HET-SR1 was highly metastatic cell line, forming about 200 foci in the lung of 100% of animals, while HET-SR cells either did not form any metastasis or formed less than five metastases in the animal's lung in about 50% of injected animals ( Figure 2b ) (Po0.001). The introduction of the shMDG1 gene significantly diminished spontaneous metastatic activity of HET-SR1 cell line (amount of metastases between two groups was compared using Mann-Whitney U-test, Po0.05). Metastatic potential of HET-SR cells was not significantly altered upon shMDG1 overexpression (Figure 2b) . Similar results were obtained using the EMA test (Figure 2c) . In EMA test, cancer cells were injected directly into blood circulation of a hamster to simulate the later phase of the metastatic process. (In SMA test, the cells were injected subcutaneously and formed the primary tumor prior to metastasis formation (Deichman et al., 1989) .) Previously, we reported that HET-SR and HET-SR1 cells were similar in EMA test (Deichman et al., 1989) . Overexpression of the shMDG considerably decreased experimental metastasis activity of HET-SR cell line about 60-fold (Figure 2c ) (Po0.001). HET-SR1/shMDG1 cells to minor extent lost their experimental metastasis activity in comparison with parental HET-SR1 cells (Figure 2c) .
Importantly, the overexpression of shMDG1 gene led to better survival of the animals with subcutaneously injected HET-SR1 (about four-fold) and intravenously injected HET-SR and HET-SR1 cells (all animals were alive in 30 days, while 10 and 40% of original HET-SR and HET-SR1 cells, respectively, died at this time point) (log-rank test, Po0.05 and Po0.01, respectively). To reveal possible mechanism underlying the ability of shMDG1 to modulate metastatic potential, we performed a set of assays estimated proliferation, clonogenesis, and migration in vitro. As measured by daily cell counts, low metastatic HET-SR and high metastatic HET-SR1 cell lines transduced by shMDG1 exhibited the same proliferation kinetics as parental cells that showed an estimated doubling time of about 30 h at exponential growth (Figure 3a) . Serum withdrawn did not elicit any difference in cells proliferation under constrained condition (doubling time of about 40 h at exponential growth). The overexpression of shMDG1 also did not affect the clonogenic ability of studied cells (Figure 3b ). The same results were obtained in analysis of anchorage-independent growth of HET-SR, HET-SR/shMDG1 and HET-SR1, HET-SR1/shMDG1 cells in soft agar (data not shown). In addition, we did not find any difference in actin cytoskeleton organization (data not shown) and migration abilities in vitro (Figure 3c ) of studied cultures. And finally, the activities of matrix metalloproteases 2 and 9 were the same in parental and shMDG1 overexpressed cell lines (data of zymography; not shown). These data indicate that the shMDG1-induced repression of metastasis is not connected with changes in cell proliferation and migration abilities that are manifesting in cell cultures in vitro. However, we could not exclude the possibility that the expression of shMDG1 influence on these processes in vivo.
The mechanism by which the shMDG1 expression affects on metastatic activity remains to be established. It was shown that the acquisition of metastatic activity was accompanied by alteration of surface glycosylation pattern (Pierce and Arango, 1986) . Numerous studies have revealed that b1,6-GlcNAc branching on N-glycans, a product of UDP-GlcNAc a-D-mannoside b1,6-N-acetylglucosaminyl transferase-V (GnTV, EC 2.4.1.155), is one of the key structure associated with tumor metastasis and malignant transformation (Dennis et al., 1987; Gu et al., 1993; Demetriou et al., 1995) . Using flow cytometry analysis, we found that overexpression of shMDG1 leads to the decreased expression of Asn-linked b1-6 branched oligosaccharides on the surface of highly metastatic HET-SR1 cells (Figure 4 ) (Po0.01). Further experiments should answer the question whether such changes are critical for modulation of metastatic potential and which cell features are changed by expression of Asn-linked b1-6 branched oligosaccharides. Detection of b1-6 branched oligosaccharides has been performed using the FITC-labeling lectin Phaseolus vulgaris (PHA-L), which specifically recognizes the 2,6-branched tri-and tetra-antennary complex (Osawa and Tsuji, 1987) . HET-SR1 cells expressed a higher number of ligands for the lectins PHA-L on their cell membrane in comparison to HET-SR and HET-SR1/shMDG1 cells. One representative experiment out of four is shown. Flow cytometry studies were performed with an EPICS ELITE flow cytometer (Coulter, Hialeah, FLA, USA). The 488 nm line of an argon laser was used as an excitation beam for the fluorochrome FITC (l ex ¼ 488 nm; l em ¼ 520 nm) and propidium iodide (Sigma) (l ex ¼ 488 nm; l em ¼ 620 nm). The data were analysed from 10 000 cells, recorded at a flow rate of 500 cells/s. Nonviable cells in each sample were detected by the addition of propidium iodide (0.5 mg/ml) to each cell sample immediately before flow cytometry analysis. Cells stained strongly with propidium iodide represented dead cells and were excluded for data acquisition purposes. Cell viability ranged from 95 to 98% in all samples.
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